STUDY SEARCH RESULTS

1 study found for your search request:  V940-007

A study of (Neo)adjuvant Intismeran autogene (V940) and pembrolizumab in cutaneous squamous cell car...
Condition: Carcinoma, Squamous Cell, Skin Neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06295809
Status: Terminated (Halted Prematurely)




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site